title: Pinellia pedatisecta agglutinin targets drug resistant K562/ADR leukemia cells through binding with sarcolemmal membrane associated protein and enhancing macrophage phagocytosis.
abstract: Pinelliapedatisecta agglutinin (PPA) has previously been used in labeling fractions of myeloid leukemia cells in our laboratory. We report here that a bacterial expressed recombinant PPA domain b tagged with soluble coxsackie and adenovirus receptor (sCAR-PPAb) preferentially recognized drug resistant cancer cells K562/ADR and H460/5Fu, as compared to their parental cell lines. Pretreatment of K562/ADR cells with sCAR-PPAb significantly enhanced phagocytosis of K562/ADR by macrophages in vivo. Meanwhile, in a K562/ADR xenograft model, intratumoral injection of sCAR-PPAb induced macrophage infiltration and phagocytosis. Furthermore, immunoprecipitation, mass spectrometry and Western blot identified the membrane target of PPA on K562/ADR as sarcolemmal membrane associated protein (SLMAP). An antibody against SLMAP significantly promoted the phagocytosis of K562/ADR by macrophages in vitro. These findings suggest that PPA not only could be developed into a novel agent that can detect drug resistant cancer cells and predict chemotherapy outcome, but also it has potential value in immunotherapy against drug resistant cancer cells through inducing the tumoricidal activity of macrophages.
authors.affiliation: College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, China.
authors.forename: Kan
authors.initials: K
authors.lastname: Chen
authors.forename: Xinyan
authors.initials: X
authors.lastname: Yang
authors.forename: Liqin
authors.initials: L
authors.lastname: Wu
authors.forename: Meilan
authors.initials: M
authors.lastname: Yu
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Li
authors.forename: Na
authors.initials: N
authors.lastname: Li
authors.forename: Shuanghui
authors.initials: S
authors.lastname: Wang
authors.forename: Gongchu
authors.initials: G
authors.lastname: Li
mesh_terms: D000373:Agglutinins / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm; D006801:Humans; D020014:K562 Cells; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology*; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D013058:Mass Spectrometry; D051379:Mice; D008813:Mice, Inbred ICR; D010587:Phagocytosis / Q000187:drug effects*; D030021:Pinellia / Q000378:metabolism*; D011485:Protein Binding; D012508:Sarcolemma / Q000378:metabolism*
chemical_list: D000373:Agglutinins; D000970:Antineoplastic Agents; D004317:Doxorubicin
references.citation: Int J Hematol. 2009 Jun;89(5):611-7
references.pmid: 19377843
references.citation: Nat Immunol. 2011 Mar;12(3):231-8
references.pmid: 21240265
references.citation: Leukemia. 2008 Jul;22(7):1395-401
references.pmid: 18509353
references.citation: J Biol Chem. 1997 Dec 19;272(51):32384-94
references.pmid: 9405447
references.citation: Neoplasma. 2009;56(1):68-71
references.pmid: 19152248
references.citation: Mol Pharm. 2011 Dec 5;8(6):1996-2011
references.pmid: 21770407
references.citation: J Immunol. 2004 Jun 15;172(12):7565-73
references.pmid: 15187136
references.citation: Breast Cancer Res. 2010;12(3):204
references.pmid: 20550729
references.citation: Mol Cancer. 2007 May 09;6:32
references.pmid: 17488527
references.citation: Eur J Immunol. 2010 Aug;40(8):2131-3
references.pmid: 20623553
references.citation: J Clin Invest. 2012 Mar;122(3):787-95
references.pmid: 22378047
references.citation: Cell. 2009 Jul 23;138(2):286-99
references.pmid: 19632179
references.citation: J Biomed Sci. 2009 Jan 19;16:10
references.pmid: 19272170
references.citation: Cell. 2009 Jul 23;138(2):271-85
references.pmid: 19632178
references.citation: J Proteome Res. 2009 Feb;8(2):483-92
references.pmid: 19072160
references.citation: Science. 2011 Mar 25;331(6024):1565-70
references.pmid: 21436444
references.citation: J Proteome Res. 2010 May 7;9(5):2565-72
references.pmid: 20235609
references.citation: J Proteomics. 2012 Sep 18;75(17):5507-15
references.pmid: 22789673
references.citation: J Proteome Res. 2012 Sep 7;11(9):4541-52
references.pmid: 22827608
references.citation: J Cell Sci. 2004 May 1;117(Pt 11):2271-81
references.pmid: 15126628
references.citation: Nat Rev Cancer. 2005 Apr;5(4):275-84
references.pmid: 15803154
references.citation: Dis Markers. 2012;33(1):1-10
references.pmid: 22710864
references.citation: Am J Physiol Heart Circ Physiol. 2012 Mar 1;302(5):H1138-45
references.pmid: 22180652
references.citation: PLoS One. 2012;7(7):e41845
references.pmid: 22844530
references.citation: Oncogenesis. 2012 Oct 15;1:e29
references.pmid: 23552401
references.citation: J Biol Chem. 2000 Dec 8;275(49):38474-81
references.pmid: 10986292
references.citation: Blood. 2012 Oct 18;120(16):3280-7
references.pmid: 22948049
references.citation: Cancer Cell. 2011 Apr 12;19(4):541-55
references.pmid: 21481794
references.citation: Curr Med Chem. 2009;16(14):1688-703
references.pmid: 19442140
references.citation: J Proteome Res. 2012 Apr 6;11(4):2508-20
references.pmid: 22309216
references.citation: Exp Diabetes Res. 2011;2011:421982
references.pmid: 21785580
references.citation: Cancer Res. 2002 Jan 15;62(2):609-16
references.pmid: 11809717
references.citation: Nature. 2007 Apr 12;446(7137):749-57
references.pmid: 17429392
references.citation: Autophagy. 2009 Feb;5(2):253-5
references.pmid: 19139634
references.citation: Blood. 2009 Jun 11;113(24):6215-24
references.pmid: 18955566
references.citation: Circ Arrhythm Electrophysiol. 2012 Dec;5(6):1098-107
references.pmid: 23064965
references.citation: Stem Cells Dev. 2012 Sep 1;21(13):2374-86
references.pmid: 22435486
references.citation: Glycobiology. 2011 Aug;21(8):1060-70
references.pmid: 21507904
references.citation: Int J Biochem Cell Biol. 2011 Oct;43(10):1442-9
references.pmid: 21798364
references.citation: J Virol. 2010 Apr;84(8):3730-7
references.pmid: 20106926
references.citation: J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):3-9
references.pmid: 19224345